Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs - Test2 - elhamkhani - TriplyDB

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

http://www.wikidata.org/entity/Q24642570

about

Molecular and therapeutic potential and toxicity of valproic acid Shortcomings in the current treatment of epilepsy Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Mood stabilizers in pregnancy and lactation Abnormal levels of Gadd45alpha in developing neocortex impair neurite outgrowth Neurodevelopmental effects of fetal antiepileptic drug exposure An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes Environmental exposures and development Women with epilepsy: clinically relevant issues Validating γ oscillations and delayed auditory responses as translational biomarkers of autism Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex.Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.Sodium valproate use is associated with reduced parietal lobe thickness and brain volume Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.Preconception care: screening and management of chronic disease and promoting psychological health Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Evaluation of Medication-mediated Effects in Pharmacoepidemiology.Increased BDNF expression in fetal brain in the valproic acid model of autism.Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study Prenatal exposure to lamotrigine: effects on postnatal development and behaviour in rat offspring Prenatal effects of antiepileptic drugs.From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.Developmental origins of health and disease: environmental exposures.Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.Another nail in the coffin.Long-term consequences after exposure to antiepileptic drugs in utero.Antiepileptic drugs in women with epilepsy during pregnancy The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs Focus on apoptosis to decipher how alcohol and many other drugs disrupt brain development.Treatment of paroxysmal dyskinesias.Teratogenic effects of antiepileptic drugs Altered cortical thickness following prenatal sodium valproate exposure Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.The treatment of women with epilepsy.New perspectives of valproic acid in clinical practice.Effects of breastfeeding in children of women taking antiepileptic drugs

P2860

Q21296867-5AD56AD1-F85A-4375-A095-BF75537D7FC5 Q22305925-A5DC4827-2876-4C85-B077-3F91F2687ACE Q24193032-9352F95E-159B-4B5C-BE19-38658AB265D0 Q24197594-6C367DC0-0A67-4D18-A5DE-FCCC10DBF1A1 Q24203023-8ACDEDA6-B58A-45FA-8B04-DE4DE2229F09 Q26741618-AD794706-AFB7-47E0-AFAB-4D6EC43F23E7 Q26795394-2B640188-467E-49B3-A14B-052C4A2882D8 Q27321056-462B0636-1F99-489C-92CE-8F8D6B3E4911 Q28080703-3BAB0849-128B-4B32-BC9D-931AB592C158 Q28081205-32C8BCB5-A387-4295-B7A3-35023ACC0D83 Q28396215-7AF5D566-470C-4B46-9477-D3E44657AFE8 Q30245064-BA579BAC-E1B6-4C58-86C3-6AEDD3C9318E Q30372103-CEF79BB3-317E-471F-96FD-F6D8DB174B12 Q30415205-5DCCAE01-9710-4A92-8D78-E21F3EEB86D2 Q30498029-C45A16C6-7C32-4B46-B228-56451D696E49 Q30540714-A5F89705-B58B-4542-9830-CD7534843B2F Q30570226-F0659978-4E73-40EB-850C-0EE591585DD0 Q30585915-97D74193-899D-407E-A704-44D2B81E1DD2 Q30592032-D91715AA-CA58-41ED-9A09-D59FF1C9B943 Q30840124-FAD0350C-66A1-4490-9195-183F9FFE408C Q33557870-751E11FF-5D15-45AA-A57B-723E612812C0 Q33560820-C9C735FD-3482-40FF-B98C-A22F74A8A71B Q33665151-AD53A206-3239-4840-B6F0-08986203075F Q33711330-4E0C6A14-8DB4-4A8B-A8C1-08D900214E43 Q33719069-B19E8B47-5FEF-4E69-A048-3570AF9EC679 Q33794480-F1B65E56-F70A-4A68-93CF-DC322EAEB185 Q33822673-3F94A8F6-140C-4189-B8FB-9FAE43D24CCD Q33861432-1C8A7473-C46B-4481-8F35-BAECBF338B72 Q33864996-6DC2A3CD-AEC2-490E-9C02-88F62588426E Q33949257-69FC4686-383A-477D-A9B4-04A2A2CB8599 Q33949402-44CC8234-17BC-4B11-9AB3-728846DEFB5E Q33970119-585AFF57-DB11-4D3A-B605-0CAF559FB905 Q33997437-793A5A49-F89A-4A1A-AE26-C861C3389AE1 Q34151861-1E321E5D-EE3A-4EDF-B1CF-E0B4778A1504 Q34267151-66B0FC42-EBCC-4EE4-9CC5-C51670D7A47B Q34287008-0C8D905E-159A-4370-B830-F069075AF421 Q34343400-7E0BF55B-E848-44CC-8DA8-73A2AC76C29A Q34363064-5DC70909-145A-4525-A3E4-7FC431E2CCA9 Q34380256-A1E009A7-F216-4CCA-AD52-ED6D8B6CED24 Q34458170-EB262C6A-ABF8-46AD-8F3E-DC4F262D915A

P2860

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

http://www.wikidata.org/entity/Q24642570

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@ast

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@en

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@nl

type

label

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@ast

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@en

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@nl

prefLabel

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@ast

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@en

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@nl

P1433

Q24642570-115F3DC0-6094-41A6-95ED-EAEC81BBA44B

P1476

Q24642570-67074617-26CE-4AF4-B734-8EF2601A7CA5

P2093

Q24642570-26769487-48BC-45CF-8796-E39CFAFB96B8

Q24642570-2DF6E6E4-52F4-4EB3-87C9-262854A1BA9D

Q24642570-3C3129F2-F7ED-4792-9024-C3308C4DCADB

Q24642570-43BED511-8680-441D-9039-E026B6756CC8

Q24642570-46262E79-098C-421F-9072-3B8C61291BB5

Q24642570-4D61BF08-83E0-42CF-A2DD-56D06E7D1EB5

Q24642570-61932A54-7206-4779-899F-DDDC6A9B1952

Q24642570-7362424B-661E-4A72-973C-CB7088A99B6E

Q24642570-A43E7BB5-F94B-4E32-9507-CDC60DB91288

Q24642570-AED69A65-77D6-4299-A182-3F1A392DAED5

P2860

Q24642570-0D59198D-E93D-4810-B9E1-C671651619C4

Q24642570-1657AD9F-C0C7-4374-BE09-3F4562141482

Q24642570-2F3F34D5-0330-42D4-9695-E5D210588C7C

Q24642570-5A1FDF19-6AA4-45F2-94F3-6CB342CA2BFD

Q24642570-64C2B3ED-0EEE-427D-806D-827FCAA5FC5C

Q24642570-895A0951-8BF5-43A0-BF85-C9D2291EA31C

Q24642570-92AF8E2D-0C5F-4682-AE0F-992BA4350AB4

Q24642570-942A9733-20F4-4ACC-902A-1BCB61006E29

Q24642570-9CE58CFB-29BA-4B23-8D90-AB22D4196B3F

Q24642570-A4BFD70C-9387-4612-AD72-ACFFBDA80BA1

P304

Q24642570-D4888A76-21FF-4AB1-8B0A-E543AC1260A4

P31

Q24642570-EDFF536D-79E2-4060-9B67-7CB0510E1FA4

P3181

Q24642570-DDA8E0AD-B1DD-4FB3-B572-536795F7CBE0

P356

Q24642570-F152E90C-9AB1-4EA5-B75D-1E1E22C5AA45

P407

Q24642570-4833935F-1358-4687-8EB0-A8D83CE9B51E

P433

Q24642570-78F01CFE-D8CA-482F-8132-86D568108CA9

P478

Q24642570-2BEF941A-E264-455C-93DF-23A0531F5189

P50

Q24642570-AF26F66E-3909-4C59-B6D0-DC36A684CF9D

P577

Q24642570-D2468E93-7CB6-4F6C-A424-9122A68DAA04

P698

Q24642570-D48AC671-711F-4ACC-8F67-EA115535A92C

P932

Q24642570-09727D57-F72C-4D1A-9892-08CFA2162240

P3181

P356

P1433

The New England Journal of Medicine

P1476

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

@en

P2093

Andres Kanner

http://www.w3.org/2001/XMLSchema#string

David W Loring

http://www.w3.org/2001/XMLSchema#string

Deborah T Combs-Cantrell

http://www.w3.org/2001/XMLSchema#string

Gus A Baker

http://www.w3.org/2001/XMLSchema#string

Joyce D Liporace

http://www.w3.org/2001/XMLSchema#string

Kimford J Meador

http://www.w3.org/2001/XMLSchema#string

Laura A Kalayjian

http://www.w3.org/2001/XMLSchema#string

Michael Privitera

http://www.w3.org/2001/XMLSchema#string

Morris Cohen

http://www.w3.org/2001/XMLSchema#string

Nancy Browning

http://www.w3.org/2001/XMLSchema#string

P2860

The longer term outcome of children born to mothers with epilepsy

Disparities in rates of unintended pregnancy in the United States, 1994 and 2001

Additional educational needs in children born to mothers with epilepsy

Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001

Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.

In utero antiepileptic drug exposure: fetal death and malformations

Variable selection for propensity score models

Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction.

Pregnancy in women who have epilepsy.

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

P304

1597-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4626415

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0803531

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Jill Clayton-Smith

P577

2009-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19369666

http://www.w3.org/2001/XMLSchema#string

P932

2737185

http://www.w3.org/2001/XMLSchema#string